CHL1 and nasopharyngeal carcinoma: Kaplan Meier’s survival analysis exhibited the remarkable prolongation of the overall survival periods in the patients with low CAPS and WFDC2, which means that CHL1, CAPS and WFDC2, etc., might be the putative molecular markers of NPC.